Authors: Lang, K Lehmann, P Bolsen, K Ruzicka, T Fritsch, C

Citation: K. Lang et al., Aminolevulinic acid: pharmacological profile and clinical indication, EXPERT OP I, 10(6), 2001, pp. 1139-1156

Authors: Monastirli, A Georgiou, S Bolsen, K Pasmatzi, E Papapanagiotou, A Goerz, G Kalofoutis, A Merk, HF Tsambaos, D

Citation: A. Monastirli et al., Treatment of porphyria cutanea tarda with oral thalidomide, SKIN PH APP, 12(6), 1999, pp. 305-311

Authors: Kalofoutis, A Monastirli, A Papapanagiotou, A Georgiou, S Pasmatzi, E Sakkis, T Bolsen, K Goerz, G Merk, HF Tsambaos, D

Citation: A. Kalofoutis et al., Alterations of rat liver phospholipid composition induced by oral thalidomide, SKIN PH APP, 12(6), 1999, pp. 312-316

Authors: Fritsch, C Lang, K von Schmiedeberg, S Bolsen, K Merk, H Lehmann, P Ruzicka, T

Citation: C. Fritsch et al., Porphyria cutanea tarda, SKIN PH APP, 11(6), 1998, pp. 321-335

Authors: Fritsch, C Lang, K Bolsen, K Lehmann, P Ruzicka, T

Citation: C. Fritsch et al., Congenital erythropoietic porphyria, SKIN PH APP, 11(6), 1998, pp. 347-357